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Introduction: Tissue engineering traditionally requires suitable scaf-
folds that allow cell maintenance and adhesion. Therefore, it’s crucial
to evaluate biomaterials as potential cell carriers. In this work, the mi-
crobeads initially developed by Gorodetsky et al. 1999 (1) using pure
ﬁbrinogen and thrombin, were obtained using complete blood plasma
making possible the production of autologous biocarriers. The resulting
particles were characterized and used as culture support of human adi-
pose mesenchymal stem cells (hAdMSC).
Materials and methods: The general aspect of produced microbeads
was scrutinized by scanning electron microscopy and their sizes deter-
mined by sieving and laser diffraction. Topography was evaluated with
Atomic force microscopy. The protein composition was analyzed by
SDS-PAGE. Human mesenchymal stem cells expressing GFP were used
to verify cell adhesion and proliferation.
Results: Size and surface features found were heterogeneous (Fig. 1,
Left). Our electrophoretic analysis showed similar pattern of bands as
those of pure ﬁbrin. Cell cultures conﬁrmed adhesion (Fig. 1, Right),
growth (Fig. 2) and optimal viability.
Figure 1 Left, Aspect of microspheres by SEM. Right, AdMSC bound to
microspheres.
Figure 2 Proliferation of hAdMSC in ﬁbrin microspheres vs conventional
ﬂask.*Absorbance is shown instead cell number because of the high
growth observed, that was out of the range predicted by the calibration
curve.
Discussion and conclusions: Our microspheres are favourable cell cul-
ture scaffolds that support cell adhesion, promote cell proliferation and
can be obtained in a wide range of sizes. They are also cheap to pro-
duce and can be used with advantage for developing autologous
implants.
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Introduction: In the last decades, adipose tissue (AT) has attracted
attention of the scientiﬁc and industrial communities for its high thera-
peutic potential. When focusing on the clinical translation of such type
of cells, aspects such as Good Manufacturing Practices (GMP) compli-
ance, scalability, reproducibility, and protocol validation must be
ensured. Manufacturing of cells must warrant high quality concerning
cell viability, cell yield immunophenotype, and absence of any microbial
or pathological contamination. This project focused on the develop-
ment of a complete manufacturing and cryopreservation process of
therapeutic cells for human clinical delivery, ensuring all parameters
and characteristics listed above.
Materials and methods: The new protocol developed is particularly
compact and ensures economies of scale when increasing the volume of
processed AT, which reduces manufacturing cost. In this project 100–
200 g AT/human donor, obtained from liposuction or lipectomy proce-
dures (n = 15) were processed under GMP conditions. Stromal vascu-
lar fraction (SVF) isolation and cryopreservation was performed using
xeno-free and GMP grade reagents. Cell number and viability, before
and after cryopreservation, was determined by trypan blue exclusion
dye by three operators. Immunophenotype of SVF subpopulations was
evaluated by ﬂow cytometry (FACSCanto and FACSDiva software) for
the expression of mesenchymal, endothelial, hematopoietic and pericy-
tic markers: CD31, CD34, CD45, CD73, CD90, CD105, CD146 and
HLA-DR. Mesenchymal trilineage differentiation was performed to
demonstrate potential of the isolated cells.
Results: The developed xeno-free cGMP procedure for isolation of clini-
cal grade SVF cells resulted in a cell yield of 2.4 9 105 0.9 cells/g AT,
and cell viability of 85.4%7.1, which demonstrated differentiation
into mesodermal lineages. After xeno-free cryopreservation cell viability
was 80.0%10.1. Regarding immunophenotype of SVF subpopulations
(Fig. 1), when considering mesenchymal markers co-expressed with
CD341, 12%5 of the cells presented the CD90+CD34+CD73+CD105+
phenotype, while 1.3%0.8 of cells expressed concomitant mesenchy-
mal markers in the absence of CD34. Regarding endothelial markers,
15%6 of the cells are CD45-CD34+CD31+. Preliminary analysis of
samples demonstrated no signiﬁcant difference of phenotypic expres-
sion before and after xeno-free cryopreservation.
Figure 1 Representative strategy of gate analysis used for hSVF charac-
terization.
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Discussion and conclusions: To the best of our knowledge this project is
pioneer in providing clinical grade cryopreserved hSVF, ensuring extre-
mely high viability post-thaw, and maintenance of immunophenotypic
characteristics of its sub-populations. This achievement is of great rele-
vance for therapeutic use of adipose tissue regenerative cells.
References
[1] Scherberich A. et al. World J Stem Cells 5, 1, 2013; 2 Bourin P. et al.
Cytotherapy. 0, 1, 2013.
OP270
Role of the stromal vascular fraction from
adipose tissue associated to a biomaterial to
regenerate bone in irradiated area
AThery1, P Blery2, O Malard1, J Guicheux2, P Pilet2, S Sourice2,
P Weiss2 and F Espitalier1
1LIOAD Inserm U791/Service de chirurgie cervico faciale,
University hospital, Nantes, France; 2LIOAD INSERM U791,
University, Nantes, France
Introduction: We have previously demonstrated that the association of
Total Bone Marrow (TBM) and Biphasic Calcium Phosphate (BCP) is
the best combination to regenerate bone in irradiated area.1 Recently,
Stromal Vascular Fraction from adipose tissue (SVF) has been described
as an alternative to TBM as a source of mesenchymal stem cells.2 Stud-
ies showed that SVF could promote osteoformation in healthy bone.3
The subject of this study was to identify the capacity of the SVF to
induce new bone formation in irradiated area.
Materials and methods: Four weeks after an external 20 Gy of irradia-
tion on the hind limbs of 20 rats, 4 bone defects were created per ani-
mal and ﬁlled with SVF or TBM, associated or not with BCP. Three
weeks after implantations, the bones were removed. Histological and
scanning electron microscopy analyses were performed to obtain quali-
tative and quantitative analyses. The different conditions were com-
pared using Mann & Whitney tests for unpaired comparisons after
validation by an analysis of Kurskal & Wallis.
Results: The BCP-TBM mixture signiﬁcantly improved bone ingrowth
(p < 0.05). The BCP-SVF mixture did not provide new-bone formation
over and above that induced by BCP alone (Fig. 1). However, the histo-
logical staining of blood vessels showed that the BCP-SVF association
induced more angiogenesis than BCP (Fig. 2).
Discussion and conclusions: Instead of the lack of vascularisation, the
lack of cytokines and growth factors in the SVF could limit bone forma-
tion when compared to TBM.
BCP associated to TBM appears to be the most efﬁcient combination
for bone reconstruction after radiotherapy today.
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Introduction: Adipose stromal cells (ASC) have been shown to exert
anti-ﬁbrotic, anti-inﬂammatory and anti-apoptotic properties, through
secreted growth factors(1,2). Basing on these characteristics have been
proposed their use for stem cell-based therapy of degenerative disease
for the treatment of osteoarthritis (OA). Therefore the aim of the study
was the analysis of trophic potential effects of ASC-conditioned med-
ium (CM) on chondrocyte and synoviocyte from OA patients.
Materials and methods: Good manufacturing practice (GMP)-clinical
grade ASC were isolated from subcutaneous adipose tissue. Chondro-
cytes and synoviocytes were isolated from cartilage and synovial of OA
patients undergoing total joint replacement. Chondrocytes or synovio-
cytes were treated with different ratio of ASC-CM or co-cultured with
ASC in transwell. Speciﬁc markers of ﬁbrosis (collagen type 1 and 3),
and matrix degrading factors and inhibitors (ADAMTS4, ADAMTS5,
TIMP1, TIMP3) were tested by RT-qPCR analysis. Secreted inﬂamma-
tory (IL6, CXCL8/IL8, CXCL1/GROa, CCL2/MCP-1, CCL3/ MIP1a,
CCL5/RANTES) and anabolic (HGF, PGE2) factors by multiplex bead--
based sandwich immunoassay or ELISA test.
Results: Chondrocyte treated with ASC-CM signiﬁcantly inhibited col-
lagen type 1 and 3 and did not affect matrix degrading factors and
inhibitors. Synoviocytes treated with ASC-CM decreased ADAMTS5
and increased ADAMTS4 expression while no effects were observed on
TIMP1 and TIMP3. By contrast, synoviocytes in co-culture experiments
conﬁrmed a decrease of ADAMTS5 associate to an increase of
TIMP1expression. The release of all the inﬂammatory factors analyzed
Figure 1 Bone ingrowth in osseous defects (*p = 0.021).
Figure 2 Sample of BCP-SVF ﬁlling with speciﬁc CD31 labeling of blood
vessels (arrow heads).
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